Founder, CEO
Expesicor
Expesicor was focused on preventing, treating, and curing neurological disorders/injuries, e.g. Alzheimer's Disease, TBI, CTE, and Epilepsy.
Led efforts to secure over $4.5M in private funding (angel and VC) and grants from multiple sources (including the National Institutes of Health). Principal Investigator on three SBIR grants. Increased company valuation by 250% in eighteen months. Quadrupled headcount in under three years.
Experienced in drug discovery/development, having conceived and led projects from discovery stage to Phase II clinical trials.
Established productive collaborations/partnerships with leading researchers and universities.
Developed an IP portfolio including multiple pending and granted patents, trademarks, and IP in-licensed from universities/companies.